Investing.com - Ideaya Biosciences (NASDAQ: IDYA) reported third quarter EPS of $-0.46, $0.03 better than the analyst estimate of $-0.49. Revenue for the quarter came in at $8.04M versus the consensus estimate of $8.14M.
Ideaya Biosciences's stock price closed at $28.93. It is up 13.45% in the last 3 months and up 60.45% in the last 12 months.
Ideaya Biosciences saw 6 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Ideaya Biosciences's stock price’s past reactions to earnings here.
According to InvestingPro, Ideaya Biosciences's Financial Health score is "good performance".
Check out Ideaya Biosciences's recent earnings performance, and Ideaya Biosciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar